Text Size

Psychostimulant Abuse - Novel Treatment Approaches - 1

This study has been completed.
Sponsor:
Collaborator:
Mclean Hospital
Information provided by:
National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:
NCT00000325
First received: September 20, 1999
Last updated: June 23, 2005
Last verified: December 2002
History of Changes
  Purpose

To determine if acute assessments of profasi and factrel affect plasma cocaine levels and cocaine-induced behavioral changes in men.


Condition Intervention Phase
Cocaine-Related Disorders
 Behavioral: Gonadorelin
 Phase 1

Study Type: Interventional
Study Design: Primary Purpose: Treatment
Official Title: Psychostimulant Abuse - Novel Treatment Approaches

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by National Institute on Drug Abuse (NIDA):

Estimated Enrollment: 0
Estimated Study Completion Date: December 2001
  Eligibility

Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria

Please contact site for information.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00000325

Locations
United States, Massachusetts
McLean Hospital, Dept. of Psychiatry
Belmont, Massachusetts, United States, 2178
Sponsors and Collaborators
National Institute on Drug Abuse (NIDA)
Mclean Hospital
Investigators
Principal Investigator: Jack Mendelson, M.D. Mclean Hospital
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00000325     History of Changes
Other Study ID Numbers: NIDA-10757-1, R01-10757-1
Study First Received: September 20, 1999
Last Updated: June 23, 2005
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Cocaine-Related Disorders
Substance-Related Disorders
Mental Disorders
Central Nervous System Stimulants
 Physiological Effects of Drugs
Pharmacologic Actions
Central Nervous System Agents
Therapeutic Uses

ClinicalTrials.gov processed this record on June 18, 2013